-
Johnson & Johnson drops OSE’s rheumatoid arthritis drug
fiercebiotech
November 05, 2018
Johnson & Johnson has dumped OSE Immunotherapeutics’ autoimmune candidate FR104. J&J picked up the rights to the CD28 antagonist for...
-
New Research Suggests Glaucoma May Be an Autoimmune Disease
drugs
August 13, 2018
The eye disease glaucoma may be an autoimmune disorder, a new study suggests.
-
Potential new approach to the treatment of multiple sclerosis
worldpharmanews
March 13, 2018
A prospective new method of treating patients with multiple sclerosis has been proposed by researchers of the Mainz University Medical Center working in cooperation with researchers of the University of Montreal.
-
Autoimmune disease research community gets boost from AMP RA/SLE study results
europeanpharmaceuticalreview
February 26, 2018
Data from the Phase I study of collaborative industry partnership AMP are now available, meaning scientists can benefit from access to important research about Rheumatoid Arthritis and Systemic Lupus Erythematosus.
-
Lilly pens deal for Evotec spinout’s immune tolerance drugs
fiercebiotech
August 23, 2017
Eli Lilly's headquartersTopas spun out of Evotec last year, picking up €14 million ($16 million) from its parent company and other investors along the way.
-
EpiVax Signs First Commercial License for Tregitope Technology
en-cphi.cn
April 26, 2017
Providence-based biotechnology company EpiVax, Inc. ("EpiVax") has licensed its novel immune-modulating technology to an undisclosed global pharmaceutical company, for use in autoimmune disease and allergy.
-
Cue Biopharma Debuts With $26 Million in Invested Capital to Develop Next-Generation Biologics to Se
firstwordpharma
January 25, 2017
Cue Biopharma, Inc. (Cue), an immunotherapy company developing biologics engineered to selectively modulate disease-relevant T cell subsets to treat cancer and autoimmune disease, announced today a total of $26 million of invested private capital, led by
-
Study Ties Inflammation, Gut Bacteria to Type 1 Diabetes
drugs.com
January 20, 2017
People with type 1 diabetes show changes in their digestive system that aren't seen in people who don't have the autoimmune disease, a new Italian study finds.